Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting von Chan, Thomas S. Y., Hwang, Yu‐Yan, Khong, Pek‐Lan, Leung, Anskar Y. H., Chim, Chor‐Sang, Tse, Eric W. C., Kwong, Yok‐Lam

Volltext

Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction von Tse, Yiu-Hei, Chan, Wing-Sze, Chim, Chor-Sang, Tse, Hung Fat

Volltext

Epigenetic silencing of MIR203 in multiple myeloma von Wong, Kwan‐Yeung, Liang, Raymond, So, Chi‐Chiu, Jin, Dong‐Yan, Costello, Joseph F., Chim, Chor‐Sang

Volltext

A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma von Wong, Kwan Yeung, Morgan, Gareth J., Boyle, Eileen M., Cheng, Alfred Sze Lok, Yip, Kevin Yuk-Lap, Chim, Chor Sang

Volltext

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients von Au, Wing-Yan, Pang, Annie, Choy, Carolyn, Chim, Chor-Sang, Kwong, Yok-Lam

Volltext

Epigenetic Silencing of Tumor Suppressor lncRNA NKILA : Implication on NF-κB Signaling in Non-Hodgkin's Lymphoma von Zhang, Min-Yue, Calin, George, Deng, Ming-Dan, Au-Yeung, Rex K H, Wang, Lu-Qian, Chim, Chor-Sang

Volltext

SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway von Chim, Chor-Sang, Fung, Tsz-Kin, Cheung, Wai-Chung, Liang, Raymond, Kwong, Yok-Lam

Volltext

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network von Soekojo, Cinnie Yentia, Kim, Kihyun, Huang, Shang-Yi, Chim, Chor-Sang, Takezako, Naoki, Asaoku, Hideki, Kimura, Hideo, Kosugi, Hiroshi, Sakamoto, Junichi, Gopalakrishnan, Sathish Kumar, Nagarajan, Chandramouli, Wei, Yuan, Moorakonda, Rajesh, Lee, Shu Ling, Lee, Je Jung, Yoon, Sung-Soo, Kim, Jin Seok, Min, Chang Ki, Lee, Jae-Hoon, Durie, Brian, Chng, Wee Joo

Volltext

Epigenetic inactivation of the MIR129-2 in hematological malignancies von Wong, Kwan-Yeung, Yim, Rita Lok-Hay, Kwong, Yok-Lam, Leung, Chung-Ying, Hui, Pak-Kwan, Cheung, Florence, Liang, Raymond, Jin, Dong-Yan, Chim, Chor-Sang

Volltext

Molecular detection of minimal residual disease in multiple myeloma von Bai, Yinlei, Orfao, Alberto, Chim, Chor Sang

Volltext

SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group von Kwong, Yok-Lam, Kim, Won Seog, Lim, Soon Thye, Kim, Seok Jin, Tang, Tiffany, Tse, Eric, Leung, Anskar Y.H., Chim, Chor-Sang

Volltext

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement von Dimopoulos, Meletios A, Hillengass, Jens, Usmani, Saad, Zamagni, Elena, Lentzsch, Suzanne, Davies, Faith E, Raje, Noopur, Sezer, Orhan, Zweegman, Sonja, Shah, Jatin, Badros, Ashraf, Shimizu, Kazuyuki, Moreau, Philippe, Chim, Chor-Sang, Lahuerta, Juan José, Hou, Jian, Jurczyszyn, Artur, Goldschmidt, Hartmut, Sonneveld, Pieter, Palumbo, Antonio, Ludwig, Heinz, Cavo, Michele, Barlogie, Bart, Anderson, Kenneth, Roodman, G David, Rajkumar, S Vincent, Durie, Brian G M, Terpos, Evangelos

Volltext

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain von Tang, Hoi Ki Karen, Fung, Chi Yeung, Morgan, Gareth J., Kumar, Shaji, Siu, Lisa, Ip, Ho Wan Alvin, Yip, Sze Fai, Lau, Ka Ngai Harry, Lau, Chi Kuen, Lee, Harold, Leung, Kwan Hung, Kho, Bonnie, Wong, Howard, Ngai, Cheong, Hwang, Yu Yan, Sim, Joycelyn, Kwong, Yok Lam, Chim, Chor Sang

Volltext

Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment von Chan, Thomas S.Y., Hwang, Yu-Yan, Gill, Harinder, Au, Wing-Yan, Leung, Anskar Y.H., Tse, Eric, Chim, Chor-Sang, Loong, Florence, Kwong, Yok-Lam

Volltext

Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced‐intensity conditioning second transplantation from the original donor von Leung, Anskar Y.H., Tse, Eric, Hwang, Yu‐Yan, Chan, Thomas S.Y., Gill, Harinder, Chim, Chor‐Sang, Lie, Albert K.W., Kwong, Yok‐Lam

Volltext

miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration von Zhang, Min Yue, Wang, Lu Qian, Chim, Chor Sang

Volltext

Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients von Chan, Thomas S. Y., Gill, Harinder, Hwang, Yu-Yan, Sim, Joycelyn, Tse, Alan C. T., Loong, Florence, Khong, Pek-Lan, Tse, Eric, Leung, Anskar Y. H., Chim, Chor-Sang, Lie, Albert K. W., Kwong, Yok-Lam

Volltext

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma von Yao, Qiumei, Bai, Yinlei, Orfao, Alberto, Chim, Chor Sang

Volltext

Epigenetic inactivation of the miR-124-1 in haematological malignancies von Wong, Kwan Yeung, So, Chi Chiu, Loong, Florence, Chung, Lap Ping, Lam, William Wai Lung, Liang, Raymond, Li, George Kam Hop, Jin, Dong-Yan, Chim, Chor Sang

Volltext

Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma von Chim, Chor-Sang, Liang, Raymond, Leung, Man-Hin, Kwong, Yok-Lam

Volltext